Sepsis Diagnostics by Microbiology Technology Market Research Report - Segmentation by Product (Assays & Reagents, Blood Culture Media, Instruments, Software); Method (Automated Diagnostics, Conventional Diagnostics); Pathogen Type (Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, Others); End User (Hospitals & Clinics, Diagnostic Centers, Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15070
Format:
Region: Global
Chapter 1. SEPSIS DIAGNOSTICS BY MICROBIOLOGY TECHNOLOGY MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. SEPSIS DIAGNOSTICS BY MICROBIOLOGY TECHNOLOGY MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. SEPSIS DIAGNOSTICS BY MICROBIOLOGY TECHNOLOGY MARKET – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. SEPSIS DIAGNOSTICS BY MICROBIOLOGY TECHNOLOGY MARK ET - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. SEPSIS DIAGNOSTICS BY MICROBIOLOGY TECHNOLOGY MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. SEPSIS DIAGNOSTICS BY MICROBIOLOGY TECHNOLOGY MARKET – By Method
6.1. Automated Diagnostics
6.2. Conventional Diagnostics
Chapter 7. SEPSIS DIAGNOSTICS BY MICROBIOLOGY TECHNOLOGY MARKET – By Product
7.1. Assays & Reagents
7.2. Blood Culture Media
7.3. Instruments
7.4. Software
Chapter 8. SEPSIS DIAGNOSTICS BY MICROBIOLOGY TECHNOLOGY MARKET – By Pathogen Type
8.1. Bacterial Sepsis
8.2. Fungal Sepsis
8.3. Viral Sepsis
8.4. Others
Chapter 9. SEPSIS DIAGNOSTICS BY MICROBIOLOGY TECHNOLOGY MARKET –By End User
9.1 Hospitals & Clinics
9.2. Diagnostic Centers
9.3. Others
Chapter 10. SEPSIS DIAGNOSTICS BY MICROBIOLOGY TECHNOLOGY MARKET – By Region
10.1. North America
10.2. Europe
10.3.The Asia Pacific
10.4.Latin America
10.5. Middle-East and Africa
Chapter 11. SEPSIS DIAGNOSTICS BY MICROBIOLOGY TECHNOLOGY MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)
11.1. bioMérieux SA (France)
11.2. Becton, Dickinson, and Company (United States)
11.3. Thermo Fisher Scientific Inc. (United States)
11.4. Bruker Corporation (United States)
11.5. Luminex Corporation (United States)
11.6. Cepheid (United States)
11.7. T2 Biosystems, Inc. (United States)
11.8. Siemens Healthineers AG (Germany)
11.9. Danaher Corporation (United States)
11.10. Immunexpress Inc. (United States)
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
Global Sepsis Diagnostics by Microbiology Technology Market is estimated to be worth USD 192.6 Million in 2022 and is projected to reach a value of USD 403.9 Million by 2030, growing at a CAGR of 9.7% during the forecast period 2023-2030.
The Global Sepsis Diagnostics by Microbiology Technology Market Drivers are the Rising Incidence of Sepsis and the Increasing Initiatives by National Governments and Non-Governmental Entities Toward the Treatment of Sepsis.
Based on the Pathogen Type, the Global Sepsis Diagnostics by Microbiology Technology Market is segmented into Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, and Others.
The United States is the most dominating country in the region of North America for the Global Sepsis Diagnostics by Microbiology Technology Market.
bioMérieux SA, Becton, Dickinson and Company, and Thermo Fisher Scientific Inc. are the leading players in the Global Sepsis Diagnostics by Microbiology Technology Market.
